Skip to main content
. 2021 Aug 24;4(10):e202101091. doi: 10.26508/lsa.202101091

Table 1.

Characteristics of enrolled patients with sepsis included in the derivation group and validation group.

Derivation group Validation group P-value
N 59 55
Male (%) 33 (55.9%) 31 (56.4%) 0.696
Age (yr) 71.0 (61.0, 78.0) 75.0 (64.0, 84.7) 0.067
Laboratory data
 Mean arterial pressure (mm Hg) 79.3 (71.5, 90.2) 77.6 (68.7, 90.0) 0.610
 White blood cell count (109/L) 12.8 (7.6, 18.4) 12.4 (7.4, 18.4) 0.933
 Haemoglobin (g/l) 114.5 (92.7, 127.0) 107.0 (83.0, 129.5) 0.432
 Haematocrit (%) 33.9 (28.3, 38.3) 32.3 (26.3, 39.3) 0.570
 Platelet count (109/L) 136.0 (68.3, 198.7) 133.0 (73.5, 174.0) 0.917
 Albumin (g/dl) 27.2 (25.0, 29.95) 27.0 (24.4, 30.8) 0.041
 Aspartate aminotransferase (U/l) 46.0 (26.5, 127.5) 40.0 (24.0, 82.0) 0.614
 Alanine aminotransferase (U/l) 30.0 (18.0, 68.0) 21.0 (14.0, 42.0) 0.144
 Total bilirubin (μmol/l) 15.8 (8.0, 26.1) 15.9 (10.9, 44.2) 0.414
 Creatinine (μmol/l) 135.0 (95.0, 218.0) 103.0 (73.5, 199.5) 0.078
 INR 1.2 (1.1, 1.3) 1.3 (1.1, 1.4) 0.818
Infection 0.832
 Gram-positive bacteria (%) 7 (11.9%) 3 (5.5%)
 Gram-negative bacteria (%) 24 (40.7%) 23 (41.8%)
 Viral (%) 1 (1.7%) 1 (1.8%)
 Other (%) 27 (45.7%) 28 (50.9%)
CRRT 8 (13.6%) 7 (12.7%) 0.246
Vasopressors 0.250
 No (%) 32 (54.2%) 33 (60.0%)
 Yes (%) 25 (42.4%) 22 (40.0%)
 Unknown (%) 2 (3.4%) 0 (0.0%)
Mechanical ventilation 0.555
 No (%) 34 (57.6%) 29 (52.7%)
 Yes (%) 22 (37.3%) 25 (45.5%)
 Unknown (%) 3 (5.1%) 1 (1.8%)
Severity at time of intensive care unit admission
 SOFA 6.0 (4.0, 8.7) 6.0 (4.0, 8.0) 0.972
 APACHE II 18.0 (11.0, 22.0) 18.0 (13.0, 23.0) 0.293
Mortality
 28-d 8 (13.6%) 10 (18.2%) 0.7
 90-d 8 (13.6%) 11 (20.0%) 0.39

Data are expressed as the mean ± SD, median (IQR) or number of patients (percentages). Continuous variables were compared by using t test and the Mann-Whitney U test, and categorical variables were compared by using the χ2 or Fisher’s exact test between the discovery and validation groups. SOFA, Sequential Organ Failure Assessment on day of sampling. APACHE II, Acute Physiology and Chronic Health Evaluation II. CRRT, Continuous Renal Replacement Therapy.